RAC — Race Oncology Cashflow Statement
0.000.00%
Last trade - 00:00- AU$738.41m
- AU$724.75m
- AU$0.79m
- 59
- 10
- 86
- 52
Annual cashflow statement for Race Oncology, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | -3.41 | -5.68 | -7.93 | -6.87 | -2.07 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -4.7 | -6.26 | -10.7 | -9.55 | -4.57 |
| Other Investing Cash Flow Items | — | — | 0 | 0 | 0 |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | — | — | 0 | 0 | 0 |
| Financing Cash Flow Items | -0.511 | -0.463 | 0 | -0.005 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 12.3 | 30.5 | -1.28 | 5.21 | 1.06 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 7.59 | 24.2 | -12 | -4.33 | -3.52 |